<DOC>
	<DOCNO>NCT01912066</DOCNO>
	<brief_summary>This phase IV clinical study evaluate preventive effectiveness NSAID-Associated Gastroduodenal Injury . The study consist multi-center , doubleblind , active-controlled , stratified randomize , parallel group . A tablet DA9601 , Cytotec ( 200ug Misoprostol ) , Acrofen ( 100mg Aceclofenac ) assign randomly subject four week .</brief_summary>
	<brief_title>A Multicenter , Double Blinded , Randomized , Parallel Assignment Study Demonstrate Efficacy DA9601</brief_title>
	<detailed_description>After fill Informed consent form , subject join clinical trial . First , Screening test include endoscopy test perform . Subjects , fit inclusion/Exclusion criterion , assign randomly . Subjects take investigation product randomize .</detailed_description>
	<mesh_term>Aceclofenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Need take NSAID pill longer four week normal diagnosed endoscopy test The patient gastric ulcer duodenal ulcer within 30 day The patient gastrointestinal surgery within year The patient take follow drug within seven day : H2 receptor antagonist , PPI , sucralfate , misoprostol , Stillen etc )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>